The dihydropyridine derivative, Bay K 8644, enhances insulin secretion by isolated pancreatic islets

Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):351-3. doi: 10.1007/BF00515566.

Abstract

The effects of the dihydropyridine derivative Bay K 8644 upon insulin secretion by perifused isolated mouse pancreatic islets were examined. At a non-stimulatory glucose concentration (5 mmol/l) Bay K 8644 (1 mumol/l) did not stimulate insulin release. However, the same drug concentration enhanced the insulin secretory responses to an intermediate (15 mmol/l) or high (30 mmol/l) glucose concentration by 80 or 90%, respectively. Bay K 8644 was half maximally effective at 0.1 mumol/l and maximally effective at 1 mumol/l. The results are compatible with the view that voltage-dependent calcium channels are essential for stimulus-secretion coupling in pancreatic B-cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Animals
  • Calcium / metabolism
  • Glucose / pharmacology
  • In Vitro Techniques
  • Insulin / metabolism*
  • Insulin Secretion
  • Ion Channels / drug effects
  • Islets of Langerhans / metabolism*
  • Male
  • Mice
  • Mice, Inbred Strains
  • Nifedipine / analogs & derivatives*
  • Nifedipine / pharmacology

Substances

  • Insulin
  • Ion Channels
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Nifedipine
  • Glucose
  • Calcium